We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

81 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

25% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 20

7% more funds holding

Funds holding: 76 → 81 (+5)

0% less capital invested

Capital invested by funds: $135M → $135M (-$360K)

15% less call options, than puts

Call options by funds: $3.26M | Put options by funds: $3.85M

Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
25
Reduced
20
Closed
7
Calls
$3.26M
Puts
$3.85M
Net Calls
-$594K
Net Calls Change
+$897K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$383K
2
BIT
BlackRock Institutional Trust
California
+$338K
3
Goldman Sachs
Goldman Sachs
New York
+$241K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$240K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$236K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$3.65M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$668K
3
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$548K
4
Allianz Asset Management
Allianz Asset Management
Germany
-$365K
5
WCM Investment Management
WCM Investment Management
California
-$148K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$51.4M +$236K +69,700 +0.5%
BFA
2
BlackRock Fund Advisors
California
$11.6M -$46.9K -13,875 -0.4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$11.2M +$383K +113,350 +4%
BIT
4
BlackRock Institutional Trust
California
$11M +$338K +100,043 +3%
DM
5
Deerfield Management
New York
$10.4M – – –
WCM Investment Management
6
WCM Investment Management
California
$6.94M -$148K -43,858 -2%
State Street
7
State Street
Massachusetts
$4.74M -$75.3K -22,275 -2%
Northern Trust
8
Northern Trust
Illinois
$3.67M -$24.9K -7,358 -0.7%
PAM
9
Panagora Asset Management
Massachusetts
$2.05M +$64.8K +19,154 +4%
SFM
10
Sphera Funds Management
Israel
$1.99M -$53.9K -15,950 -3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.96M +$240K +71,113 +16%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$1.6M +$145K +42,833 +11%
TCIM
13
TIAA CREF Investment Management
New York
$1.38M -$41.6K -12,300 -3%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$1.12M -$668K -197,657 -40%
BIM
15
BlackRock Investment Management
Delaware
$919K +$18.7K +5,524 +2%
BCM
16
Bridgeway Capital Management
Texas
$838K – – –
Charles Schwab
17
Charles Schwab
California
$732K – – –
BP
18
Banyan Partners
Florida
$725K – – –
TC
19
TFS Capital
Pennsylvania
$716K +$97.9K +28,950 +18%
Group One Trading
20
Group One Trading
Illinois
$580K +$215K +63,525 +69%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$568K +$5.63K +1,667 +1%
ABI
22
Adamant Biomedical Investments
Switzerland
$558K +$507K +150,000 New
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$556K – – –
TA
24
Teachers Advisors
New York
$507K +$24.2K +7,165 +6%
OC
25
Oppenheimer & Co
New York
$495K +$95.8K +28,350 +27%
1
2 3 4

IMMU Hedge Fund Activity: Q3 2014 in Review

81 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2014, worth a combined $135M — down 0.27% from $135M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.

The largest buyer was Vanguard Group, adding an estimated $383K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.65M sold.

  • 81 institutional investors held Immunomedics Inc (IMMU) as of Q3 2014, up from 76 in Q2 2014.
  • Funds reported $135M of Immunomedics Inc stock for Q3 2014, down 0.27% quarter-over-quarter.
  • 12 funds opened new Immunomedics Inc positions in Q3 2014 and 7 closed out, a net change of +5 holders.
  • The largest Immunomedics Inc buyer in Q3 2014 was Vanguard Group, an estimated $383K added.
  • The largest Immunomedics Inc seller in Q3 2014 was RA Capital Management, an estimated $3.65M sold.

Based on aggregated 13F filings for Q3 2014.